Not yet available on the NHS: UK access awaits successful phase 3 results, regulatory approval and a positive NICE appraisal
After its expiration date, the medication may not work as well for weight loss, weight maintenance, or blood sugar control
You experienced acute pancreatitis or intestinal blockages linked to GLP-1 drugs
According to CDC estimates, 80% of US adults with prediabetes are undiagnosed and unaware
Ongoing clinical trials are exploring its efficacy and safety, positioning it as a promising option for patients with complex metabolic conditions
Compounding continues under different exemptions: Customized formulations: Adding B12, adjusting dose strengths not commercially available, providing allergen-free preparations Medical-need exemptions: Patient-specific reasons the brand product cannot be used (allergy, intolerance, dosing requirements) Patient access exceptions: Insurance non-coverage combined with documented medical need can support compounding for cash-pay patients in some state interpretations Reputable compounding pharmacies and the telehealth platforms that work with them have restructured their patient-intake processes to document medical-need rationale on every prescription